Casdin Capital’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-20,000
| Closed | -$451K | – | 46 |
|
|
2022
Q3 | $451K | Sell |
20,000
-130,938
| -87% | -$2.95M | 0.03% | 34 |
|
|
2022
Q2 | $2.9M | Sell |
150,938
-22,404
| -13% | -$430K | 0.25% | 35 |
|
|
2022
Q1 | $8.04M | Sell |
173,342
-70,507
| -29% | -$3.27M | 0.36% | 40 |
|
|
2021
Q4 | $17.3M | Hold |
243,849
| – | – | 0.49% | 38 |
|
|
2021
Q3 | $28.4M | Buy |
243,849
+34,722
| +17% | +$4.04M | 0.71% | 36 |
|
|
2021
Q2 | $32.7M | Hold |
209,127
| – | – | 0.83% | 30 |
|
|
2021
Q1 | $39.6M | Hold |
209,127
| – | – | 1.18% | 24 |
|
|
2020
Q4 | $26.2M | Hold |
209,127
| – | – | 0.78% | 28 |
|
|
2020
Q3 | $22.8M | Hold |
209,127
| – | – | 1.02% | 23 |
|
|
2020
Q2 | $25.1M | Buy |
209,127
+23,437
| +13% | +$2.82M | 1.49% | 24 |
|
|
2020
Q1 | $18.7M | Sell |
185,690
-7,943
| -4% | -$798K | 1.98% | 18 |
|
|
2019
Q4 | $47M | Buy |
193,633
+3,125
| +2% | +$758K | 4.32% | 11 |
|
|
2019
Q3 | $31.3M | Buy |
190,508
+2,813
| +1% | +$462K | 3.24% | 12 |
|
|
2019
Q2 | $44.3M | Buy |
187,695
+22,488
| +14% | +$5.31M | 4.15% | 11 |
|
|
2019
Q1 | $43.5M | Hold |
165,207
| – | – | 4.78% | 8 |
|
|
2018
Q4 | $15.1M | Buy |
165,207
+24,531
| +17% | +$2.24M | 2.58% | 17 |
|
|
2018
Q3 | $27M | Buy |
140,676
+13,437
| +11% | +$2.58M | 3.29% | 13 |
|
|
2018
Q2 | $27.5M | Buy |
+127,239
| New | +$27.5M | 3.84% | 11 |
|